FDA data Registry peer set 3 peers

Alternatives to levomilnacipran

3 same-class SPL records vs levomilnacipran - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Fetzima

Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Prescription 3 alternatives found

About levomilnacipran

Fetzima is a medicine used to treat major depressive disorder (MDD) in adults. It helps to improve your mood by affecting certain chemicals in the brain.

Used for: Fetzima is used to treat major depressive disorder (MDD) in adults. MDD can cause you to feel sad, lose interest in activities, and have trouble with daily life. Fetzima can help improve your mood and reduce these symptoms.

3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) peers (wide set)

Compare levomilnacipran vs desvenlafaxine side-by-side →

levomilnacipran vs desvenlafaxine & duloxetine · FAERS reaction fields

FAERS top-reaction field "Pain" shows the widest count spread between levomilnacipran and desvenlafaxine, duloxetine, venlafaxine in this extract (3,487-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect levomilnacipran desvenlafaxineduloxetinevenlafaxine
Pain 210 117 3,697 2,590
Vomiting 208 - 2,456 2,421
Memory Impairment 189 - - -
Paraesthesia 179 - - -
Hypoaesthesia 178 - - -
Abdominal Pain Upper 175 - - -
Migraine 170 - - -
Gastrooesophageal Reflux Disease 168 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

levomilnacipran peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for Serotonin-Norepinephrine Reuptake Inhibitor (SNRI): 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside levomilnacipran?
This registry lists 3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) medication records beside levomilnacipran, including desvenlafaxine, duloxetine, venlafaxine. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) peer set (3 records)

levomilnacipran (Fetzima) sits in a wide Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) peer set (3 of 3 class peers shown). Labeled indication field for levomilnacipran: Fetzima is used to treat major depressive disorder (MDD) in adults.

Top FAERS reaction fields for levomilnacipran total 1,789 reports across 10 reactions, set beside desvenlafaxine, duloxetine, venlafaxine. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full levomilnacipran profile →

Field note for levomilnacipran: see also the generic vs brand label guide when reading Fetzima SPL strings.